about
Adoptive immunotherapy against ovarian cancerT-Cell-Based Immunotherapy for Osteosarcoma: Challenges and OpportunitiesImmunological and Translational Aspects of NK Cell-Based Antitumor ImmunotherapiesZoledronic acid sensitizes rhabdomyosarcoma cells to cytolysis mediated by human γδ T cells.Cytokines induced killer cells produced in good manufacturing practices conditions: identification of the most advantageous and safest expansion method in terms of viability, cellular growth and identity
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Adoptive immunotherapy against sarcomas.
@en
type
label
Adoptive immunotherapy against sarcomas.
@en
prefLabel
Adoptive immunotherapy against sarcomas.
@en
P2093
P2860
P50
P1476
Adoptive immunotherapy against sarcomas
@en
P2093
Fabrizio Carnevale Schianca
Loretta Gammaitoni
Michela Cangemi
Ramona Rotolo
P2860
P304
P356
10.1517/14712598.2015.987121
P407
P50
P577
2014-12-16T00:00:00Z